# A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

> **NCT00864201** · PHASE3 · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 10 (estimated)

## Conditions studied

- Hypertension, Pulmonary
- Connective Tissue Disease

## Interventions

- **DRUG:** bosentan

## Key facts

- **NCT ID:** NCT00864201
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864201, "A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00864201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*